Reply Re: "Teprotumumab for the Treatment of Recalcitrant Thyroid Eye Disease".
Men CJ, Amarikwa L, Pham B, Sears C, Clauss K, Lee BW, Lee WW, Pasol J, Ugradar S, Shinder R, Cockerham K, Wester S, Douglas R, Kossler AL.
Men CJ, et al. Among authors: lee ww.
Ophthalmic Plast Reconstr Surg. 2025 Jan-Feb 01;41(1):111-112. doi: 10.1097/IOP.0000000000002875. Epub 2025 Jan 3.
Ophthalmic Plast Reconstr Surg. 2025.
PMID: 39752221
No abstract available.